机译:CGHRA框架在弥漫性大B细胞淋巴瘤的基因组特征中的应用
INSERM Team Genom &
Biomarkers Lymphoma &
Solid Tumors U1245 Ctr Henri Becquerel F-76000 Rouen France;
INSERM Team Genom &
Biomarkers Lymphoma &
Solid Tumors U1245 Ctr Henri Becquerel F-76000 Rouen France;
INSERM Team Genom &
Biomarkers Lymphoma &
Solid Tumors U1245 Ctr Henri Becquerel F-76000 Rouen France;
Univ Lille II Plate Forme Genom Fonct &
Struct F-59000 Lille France;
Univ Lille II Plate Forme Genom Fonct &
Struct F-59000 Lille France;
INSERM Team Genom &
Biomarkers Lymphoma &
Solid Tumors U1245 Ctr Henri Becquerel F-76000 Rouen France;
INSERM Team Genom &
Biomarkers Lymphoma &
Solid Tumors U1245 Ctr Henri Becquerel F-76000 Rouen France;
INSERM Team Genom &
Biomarkers Lymphoma &
Solid Tumors U1245 Ctr Henri Becquerel F-76000 Rouen France;
INSERM Team Genom &
Biomarkers Lymphoma &
Solid Tumors U1245 Ctr Henri Becquerel F-76000 Rouen France;
INSERM Team Genom &
Biomarkers Lymphoma &
Solid Tumors U1245 Ctr Henri Becquerel F-76000 Rouen France;
INSERM Team Genom &
Biomarkers Lymphoma &
Solid Tumors U1245 Ctr Henri Becquerel F-76000 Rouen France;
INSERM Team Genom &
Biomarkers Lymphoma &
Solid Tumors U1245 Ctr Henri Becquerel F-76000 Rouen France;
INSERM Team Genom &
Biomarkers Lymphoma &
Solid Tumors U1245 Ctr Henri Becquerel F-76000 Rouen France;
机译:CGHRA框架在弥漫性大B细胞淋巴瘤的基因组特征中的应用
机译:免疫组织化学的实际应用:弥漫性大B细胞淋巴瘤和相关大B细胞淋巴瘤的评估(第139卷,第1094页,2015年)
机译:弥漫性大B细胞淋巴瘤及相关大B细胞淋巴瘤免疫组织化学评估的实际应用
机译:弥漫性大B细胞淋巴瘤与中枢神经系统复发的突变特征:用于癌症基因组学数据库的CBioPortal分析
机译:免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性:RU051417I-R-ICE(利妥昔单抗-异环磷酰胺-卡铂-依托泊苷)与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤(DLBCL)。
机译:使用阵列比较基因组杂交(aCGH)的浆母细胞性淋巴瘤的基因组分析:揭示了明显的重叠基因组病变和弥漫性大B细胞淋巴瘤
机译:使用阵列比较基因组杂交(aCGH)的浆母细胞性淋巴瘤的基因组分析:揭示了明显的重叠基因组病变和弥漫性大B细胞淋巴瘤